MEN1 and acute myeloid leukemia: This review will discuss the evolution of menin as a target in AML therapeutics, the clinical development of various menin inhibitor and outcome data from the latest clinical trials, and the understanding of its resistance mechanisms and strategies to improve outcomes and future directions.